trending Market Intelligence /marketintelligence/en/news-insights/trending/uQYl01rMSuig6VwX44B0lw2 content esgSubNav
In This List

Stellar Biotechnologies expands board

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

Blog

Essential IR Insights Newsletter - February 2023


Stellar Biotechnologies expands board

Stellar Biotechnologies Inc. added Charles Olson and Paul Chun to its board of directors.

Olson is Anthera Pharmaceuticals Inc.'s chief technology officer and a biotechnology consultant for Compass Biotechnology LLC. He has been a member of Stellar's scientific advisory board since June 2014.

Chun is managing partner and founder of life sciences-focused advisory company Eldred Advisors LLC.